A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease

被引:54
作者
Woodward, M.
Rumley, A.
Welsh, P.
Macmahon, S.
Lowe, G.
机构
[1] Univ Glasgow, Div Cardiovasc Med Sci, Royal Infirm, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Sydney, Inst Geog, Sydney, NSW 2006, Australia
[3] Mt Sinai Med Ctr, New York, NY 10029 USA
关键词
coagulation; coronary heart disease; fibrinolysis; inflammation;
D O I
10.1111/j.1538-7836.2007.02677.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: While meta-analyses of prospective studies have established that plasma levels of several hemostatic variables are associated with the risk of coronary heart disease (CHD), these have been suggested to be acute-phase reactant proteins. This study examines their associations with inflammatory markers [C-reactive protein (CRP) and interleukin-6 (IL-6)] and the effect of adjustment on their associations with CHDrisk. Methods and results: In a nested case-control study, 247 CHD cases and 473 controls were matched for age and sex from 10 529 men and women in the Fletcher Challenge cohort. Plasma levels of all hemostatic variables except von Willebrand factor (VWF) and lipoprotein (a) [Lp(a)] showed significant associations with CRP and IL-6. Fibrinogen, VWF, tissue plasminogen activator antigen (t-PA), D-dimer, Lp(a), CRP and IL-6 levels were significantly associated with risk of CHD. After adjustment for conventional risk factors, CRP, D-dimer and IL-6 levels were significantly associated with risk of CHD. On further adjustments for the other six hemostatic and inflammatory variables these associations were reduced, but remained significant for D-dimer and IL-6; odds ratios (95% CI), comparing the highest to lowest third, were 3.10 (1.25-7.67) and 2.79 (1.11-6.99), respectively. Conclusion: The associations of plasma levels of some hemostatic variables (fibrinogen, VWF, t-PA and Lp(a); but not fibrin D-dimer) with CHD risk are attenuated when inflammatory markers (CRP and IL-6) as well as conventional risk factors are included in multivariable analyses. D-dimer and IL-6 each have the potential to increase the prediction of CHD, in addition to conventional risk factors.
引用
收藏
页码:1795 / 1800
页数:6
相关论文
共 28 条
  • [1] Insight into the nature of the CRP-coronary event association using Mendelian randomization
    Casas, Juan P.
    Shah, Tina
    Cooper, Jackie
    Hawe, Emma
    McMahon, Alex D.
    Gaffney, Dairena
    Packard, Christopher J.
    O'Reilly, Denis S.
    Juhan-Vague, Irene
    Yudkin, John S.
    Tremoli, Elena
    Margaglione, Maurizio
    Di Minno, Giovanni
    Hamsten, Anders
    Kooistra, Teake
    Stephens, Jeffrey W.
    Hurel, Steven J.
    Livingstone, Shona
    Colhoun, Helen M.
    Miller, George J.
    Bautista, Leonelo E.
    Meade, Tom
    Sattar, Naveed
    Humphries, Steve E.
    Hingorani, Aroon D.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (04) : 922 - 931
  • [2] Clarke R, 1999, AM J EPIDEMIOL, V150, P341
  • [3] Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies
    Danesh, J
    Collins, R
    Peto, R
    [J]. CIRCULATION, 2000, 102 (10) : 1082 - 1085
  • [4] Danesh J, 2001, CIRCULATION, V103, P2323
  • [5] Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis
    Danesh, J
    Lewington, S
    Thompson, SG
    Lowe, GDO
    Collins, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14): : 1799 - 1809
  • [6] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies
    Danesh, J
    Collins, R
    Appleby, P
    Peto, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1477 - 1482
  • [7] C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
    Danesh, J
    Wheeler, JG
    Hirschfield, GM
    Eda, S
    Eiriksdottir, G
    Rumley, A
    Lowe, GDO
    Pepys, MB
    Gudnason, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) : 1387 - 1397
  • [8] Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis:: serum levels and relationship to inflammation
    Dursunoglu, D
    Evrengül, H
    Polat, B
    Tanriverdi, H
    Çobankara, V
    Kaftan, A
    Kiliç, M
    [J]. RHEUMATOLOGY INTERNATIONAL, 2005, 25 (04) : 241 - 245
  • [9] When is a new prediction marker useful?: A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk
    Greenland, P
    O'Malley, PG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) : 2454 - 2456
  • [10] Fibrinogen and coronary heart disease:: test of causality by 'Mendelian randomization'
    Keavney, Bernard
    Danesh, John
    Parish, Sarah
    Palmer, Alison
    Clark, Sarah
    Youngman, Linda
    Delepine, Marc
    Lathrop, Mark
    Peto, Richard
    Collins, Rory
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (04) : 935 - 943